Month: December 2023

Insider Buying Week 12-29-23 Here We go Again with Rampant Speculation

by

Here we go again, two insider buys in small biotech names that rocketed 43% and 76% last week.  This didn’t happen in a vacuum. For the last two months or so,  the daily top 50 largest percentage gainers and losers are filled with small-cap and bulletin board names you’ve never heard of, ripping up and down 40%-150% in a shark-like blood-infested feeding frenzy. The list is composed mostly of obscure biotech stocks, pre-revenue or little revenue shells, SPACS, and cryptocurrency names, scams, and fantasies inspired by occasional real biotech transactions, the most notable being the 273% premium Sanofi paid for … Read more

‘s Retreat Continues to Spike the Market

by

While some stocks like the Magnificent Seven have had a phenomenal comeback year, many, many companies are depressed in value. For example, many REITs have poor returns, some as a consequence of the sharp rise in interest rates. Agree Realty had a return of -15.34% year-to-date (YTD.) Paying particular attention to significant insider buying is one way to force that discipline of buying cheaply on yourself. When not painting the tape or participating in required corporate ownership requirements, insiders are historically value buyers. This week, we highlight what we think are notable buys. Although we pay attention to selling, we … Read more

Insider Buying Week 12-15-23 Glad to See some Big Names and Big Dollars Returning to the Insider Buying Game

by

While some stocks like the Magnificent Seven have had a phenomenal comeback year, many, many companies are depressed in value. We have no shortage of compelling investment ideas, but getting people to invest when values are low is the opposite of human nature. Paying particular attention to significant insider buying is one way to force that discipline on yourself. When not painting the tape or participating in required corporate ownership requirements, insiders are historically value buyers.  This week, we highlight what we think are notable buys. Although we pay attention to selling, we don’t write about this far more nuanced … Read more

Insider Buying Week 12-08-23 Energy Swooned, Some Insiders Stepped Up

by

As we go into the final turn of the year, expect some modest profit-taking in the Magnificent Seven. I expect some good opportunities if mortgage rates drop enough for people trapped in their homes to make a move. The purchase this week by National Storage’s Co-Chairman adds some credence to this. The stock has already rallied significantly, but storage should grow if we pick up the American tradition of musical chairs and home swapping. As EV demand wanes and the threat of hydrocarbons being replaced by renewables seems more like fantasy than policy, oil prices fall to levels not seen … Read more

Insider Buying Week 12-01-23 AI will Improve everything but the Tesla pickup truck

by

FOMO  (fear of missing out in a year when the S&P is up over 20%) is in full swing. One thing not making the headlines is the market is essentially where it was two years ago, with investors on a roller coaster ride.  AI will improve everything except the Tesla pickup, and gasoline is the cheapest at the pump in years, even as the world seems to be throwing in the towel on preventing climate change. All that ESG and green talk seems to be more expensive than anyone wants to pay for. The magnificent seven took the week off … Read more

"The insomniac hedge fund guy" is a moniker Harvey Sax, the portfolio manager for The Insiders Fund has used from time to time on email, blog , and social media posts. While Mr. Sax is the portfolio manager of The Insiders Fund, these posts are not communications from, nor endorsed by, Alpha Wealth Funds, LLC or any of its managed funds. References to Alpha Wealth Funds or its affiliates are for identification only and do not imply sponsorship or approval. All registered trademarks herein are the property of their respective owners.

© 2026 Insomniac Hedge Fund Guy